Brain injury | Brain injury Conference | Brain injury Conferencs | Brain injury Event |Brain injury Congress |Neurosurgery Conference | Neurology Conference | Brain Conference |Prague | Czech Republic | Europe

Theme: Explore the Latest Innovative Treatment and Prevention of Brain Injury

Brain Injury 2018

Scientific Program

Renowned Speakers

Trevor Archer
Professor University of Gothenburg
Sweden

Thomas F. Feiner
Director Institute for EEG-Neurofeedback
Germany

Wai Kwong Tang
Chinese University of Hong Kong
China

Steven Benvenisti
Partner at Davis, Saperstein & Salomon Personal Injury Law Firm NJ & NY
USA

Adrian GaitÃ¡n FariÃ±as
IFEN institute for EEG Neurofeedback Gaitan Clinics
Spain

Albert Karimov
Infomed-Neuro
Russia

Hemanth Rao
The Neurological Institute
USA

Anatoly Uzdensky,
Southern Federal University,
Russia

Reza Amani
Isfahan University of Medical Sciences
Iran

Raed Mohammad Odeh Aljubour
Consultant Neurosurgeon KHMC,
Jordan

Lena Ehrhard
â€“ Institute for EEG-Neurofeedback Munich
Germany

Jing Fu
Macau University of Science and Technology
China

Hashim Balubaid
king Abdulaziz university
Saudi Arabia

Sanjay Deshpande
Consultant in Anesthetics and Intensive Care
UK

Anthony Lee

USA

AurÃ©lien NDOUMBE

Cameroon

Khaled AlHourani

Jordan

Waleed Jarjoura

Palestine

Damlaa Anil

Turkey

Brain Injury 2018

Track 1: Neurological Disorders

Neurological disorders are the diseases of central and peripheral nervous system. Like brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction. Disorders such as epilepsy, Alzheimer disease, dementias, cerebrovascular diseases which includes stroke, migraine and headache disorders, multiple sclerosis, Parkinson's disease, neuroinfections, brain tumours, traumatic disorders of nervous system due to head trauma, and neurological disorders as a result of malnutrition.

14^th World Congress on Neurology and Neurological Disorders July 17-18, 2017 Chicago, USA: 3^rd International Conference on Central Nervous System Disorders & Therapeutics Oct 02-04, 2017 Vienna, Austria: 18^th Global Neurologists Annual Meeting on Neurology and Neurosurgery Nov 13-15, 2017, Athens, Greece: 5^th International Conference on Neurological Disorders and Stroke November 13-14, 2017 London, UK: 20^th Annual Meeting on Neurology and Neurosurgery Nov 27-28, 2017 Dubai, UAE: 5^th International Conference on Brain Disorders and Therapeutics Nov 29 - Dec 01, 2017 Madrid, Spain: 11^th International Conference on Vascular Dementia February 22-23, 2018 Paris, France: 20^th International Conference on Neuroscience and Neurochemistry February 26-27, 2018 Berlin, Germany: 21^st World Congress on Neurology and Therapeutics March 15-17, 2018 London, UK: 23^rd International Conference on Neurology and Neurophysiology April 23-25, 2018 Rome, Italy: 3^rd International Conference and Exhibition on Dual Diagnosis June 11-13, 2018 London, UK

Related Societies:

Neuropathy Association & Nevus Outreach, Brain Aneurysm Foundation and Brain Injury Association of America, Brain Injury Resource Center & Brain Trauma Foundation; Brain Research Organisation; International Child Neurology Association; World Federation of Neurology; World Federation for Neuro Rehabilitation; World Federation of Neurosurgical Societies; World Psychiatric Association; Alzheimer's Disease International; Association of Parkinsonism and Related Disorders

Track 2: Brain Injury

Brain Injury is a common term which is used to describe any trauma to the head or brain but most specifically to the brain itself. There are several types of head injuries may occur such as skull fractures, intracranial haemorrhage like subdural or epidural hematoma. Treatment of a head or brain injury depends mainly on the cause and the severity of the injury.

Track 3: Brain Disorder

Brain disorders are one of the most serious health problems facing our society .Brain disorders or Brain damage includes many conditions that can affect your brain. Those conditions that are caused by illness, genetics, or brain injury.

When the brain is damaged, it can affect many different things, such as memory, sensation, and functions. The brain is susceptible to different disorders that strike at every stage of our life. They are also the most mysterious of all diseases.

There are about 10 million people in the UK living with the neurological condition which has a very significant impact on their lives. Mainly stroke, Depression dementia, headache, Brain injury and epilepsy are the neurological conditions suffered in UK. It has been estimated that the lifetime risk of developing Brain and other central nervous system cancer is 1 in 133 for men and 1 in 185 for women in the UK.

Track 4: Developmental disorders

These are a group of psychiatric conditions originating in childhood that includes serious impairment in different areas.These disorders comprise language disorders, learning disorders, motor disorders and autism spectrum disorders. One of the most common developmental disorders is mental retardation. More than one out of every 100 school children in the United States has mental retardation. Second Development disorder is the Cerebral palsy, and next autism spectrum disorders. In definitions Attention-deficit/hyperactivity disorder is included, and the term used is neurodevelopmental disorders.

Track 5: Dementia

Dementia is a chronic and higher intellectual function due to organic brain disease. Dementia is condition in which a person loses their ability to think, remember, learn, and to make decisions, and solve the problems. It may also include like personality changes and emotional problems. Some other problems like decrease in motivation emotional problems and problems with language.

Globally, dementia affected total of 46 million people in 2015. About 10% of people develop this disorder at any some point of their lives. By ages 3% of the people between the ages 65–74 have dementia, and 19% of people between the age 75 and 84 and nearly half of those over 85 years of age. In 2013 dementia was resulted in about 1.7 million deaths in 1990. As more number of people are living longer, dementia is becoming very common in population as a whole. It is to be believed to result in economic costs of 604 billion USD per year.

Track 6: Neurodegenerative Disorder

Neurodegenerative disorder is the progressive loss of structure or function of the neurons, including the death of the neurons. Some of the neurodegenerative diseases are Multiple sclerosis, Parkinson's, Alzheimer's, Motor neurone diseases, and Huntington's occur as a result of neurodegenerative processes. Such diseases are mostly incurable, resulting in progressive degeneration or death of the neuron cells. Neurodegeneration can found in the many different levels of neuronal circuitry ranging from the molecular to systemic.

Based on regions, global neurodegenerative disease market is segmented into the seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa. Global market for neurodegenerative disease is expected to grow by a CAGR are of around 5%. Asia Pacific is expected to witness the highest growth due to the large population base over the forecast years.

Track 7: Peripheral neuropathy

Peripheral Neuropathy is damage or disease that affects the nerves, which may be impair sensation, movement, gland or organ function, and other aspects of health, depending on type of nerve affected. Some common causes include systemic affect which causes diseases such as diabetes, vitamin deficiency, and medication. Peripheral neuropathy may be chronic or acute. Acute neuropathies demand for urgent diagnosis. Motor nerves, sensory nerves, or autonomic nerves may be affected. Peripheral neuropathies may be classified according to the type of nerve involved, or by the underlying cause.

Geriatric and obese population people are at high risk for the developing peripheral neuropathy. Centers for Disease Control and Prevention stated, that the people who are diagnosed with diabetes mostly are obese. so, with the rising in geriatric population and growing prevalence of diabetes propels the demand of global market to peripheral neuropathy treatment. According to World Health Organization, the global geriatric population increase from 524 million in 2010 to about 2 billion by the year 2050. World Health Organization stated in the year 2012 that, more than the 40 million children under the age of 5 were overweight. And it has also estimated that 10% of the world population of adult was obese in 2012.

Track 8: Central Nervous System Disorder

Neurological disorder is any disorder that belongs to nervous system. Structural, biochemical or electrical abnormalities in brain, spinal cord and other nerves can result in a range of symptoms. Some symptoms like paralysis, loss of sensation, seizures, confusion, and pain.

World Health Organization estimated in the year 2006 that neurological disorders affect one billion people worldwide.

Market of CNS disorders are categorized into three segments, psychiatry, neurology and pain drugs market.. Among these the psychiatry segment has the largest share that accounting for more than 40% next followed by neurology and pain segment. As of year 2012, world health organization said that about 50 million people are suffering from epilepsy worldwide most of them belong to developing nations.

Track 9: Brain Stroke

Stroke is when there is a poor blood flow to the brain that results in cell death. There are two types of stroke 1) ischemic stroke which is defined as lack of blood flow to the brain, 2) haemorrhagic stroke which occurs due to bleeding. These result in part of the brain not functioning properly. Symptoms like inability to move or feel on one side of the body, feeling like the world is spinning, or loss of vision. If the symptoms last in less than one or two hours then it is known as a transient ischemic attack also known as mini-stroke. A haemorrhagic stroke associated with a severe headache. The symptoms of a stroke can be permanent.

In 2013 about 6.9 million people had an ischemic stroke and about 3.4 million people had a haemorrhagic stroke. In 2015 about 42.4 million people who had previously had a stroke and they were still alive. In between 1990 and 2010 the number of strokes which occurred each year was decreased by 10% in the developed world and increased by approximately 10% in the developing world. After coronary artery disease, death cause by the stroke was in second place in 2015. About half of the people who have had a stroke live less than the one year.

Track 10: Spinal Cord disorder

Spinal cord is main pathway for the communication between the brain and the rest of the body. It is a long, and fragile, tube like structure that extends downward from base of the brain.

Mostly pinal stenosis affects the people at age of 60 and also occur in younger people born with the abnormal spinal canal. Lumbar spinal stenosis, cervical spinal stenosis and thoracic spinal stenosis are the three types of spinal stenosis. Mostly 75% of the cases of spinal stenosis occur in the lower lumbar region.

Track 11: Psychiatric disorder

It is a mental disorder, or mental illness. The causes of mental disorders are unknown. Mental disorders are explained by the combination of behaviour of the person , or feels, or thinks. This are associated with the particular regions or functions of the brain.

Globally Some common mental disorders include depression, that affects about 400 million, dementia which affects about 35 million, schizophrenia, that affects about 21 million people . WHO stated that 350 million populations is suffering with depression and mental disorders and approximately 24 million populations globally is affected by schizophrenia disorder. According to the survey conducted by CPA in the year 2012, about 77% of patient population receive psychotherapy are benefited or remained generalized anxiety disorder free after the treatment.

Related Societies:

Neuropathy Association & Nevus Outreach, Brain Aneurysm Foundation and Brain Injury Association of America, Brain Injury Resource Center & Brain Trauma Foundation; Brain Research Organisation; International Child Neurology Association; World Federation of Neurology; World Federation for Neuro Rehabilitation; World Federation of Neurosurgical Societies; World Psychiatric Association; Alzheimer's Disease International; Association of Parkinsonism and Related DisordersTrack 10: Neuroimaging

Neuroimaging is also called as brain imaging which includes various techniques to image the morphology, functioning of the nervous system. It is a new discipline within medical knowledge.

Neuroradiology is a subspecialty of radiology that focusing on the diagnosis and characterization of abnormalities of the central and peripheral nervous system, spine and head and neck using neuroimaging techniques. It includes computed tomography (CT) and magnetic resonance imaging.

During 2066-2015 as per global report 582 patients were hospitalized with neurological disorders and the ratio of the patients having neuro-CTs raised by 86% to 88%, neuro-MRs by 79%-93%, and requirement of ICU care increased 17% to 26%.

Related Societies:

Track 12: Brain mapping

Brain mapping is a technique or method which is used for the study of the structure and functions of different parts of the brain. Brain mapping is used for recording of brain wave activities. Brain mapping helps for surgeons in identifying brain areas which is responsible for critical functions of the body like locomotion, vision, sensation, and speech. Brain mapping helps in detection of various abnormalities such as tumours, seizures (partial, incomplete, complete) toxic injuries, Alzheimer disorders, infections. Brain mapping also helps in identifying the external environment, physical injuries. It is done by stimulation of certain brain areas that which perform language, motor, sensory, and visual functions. Brain-mapping instruments are computed tomography, positron emission tomography, electroencephalography, near-infrared spectroscopy, magneto encephalography, and functional magnetic resonance imaging. These techniques help in measuring cerebral blood flow, metabolism, and structural integrity of the brain. It is performed in two ways two-stage procedures and directly during surgery. Brain mapping, performed during surgery, is known as intraoperative brain mapping. The brain mapping procedure time depends upon targeted brain tissues for surgery and locations of surgery

Related Societies:

Track 13: Neurosurgery

Neurosurgery is a highly specialized medical field which focused on surgical treatment of brain and spine disorders. It is a complex surgical procedure which involves diagnosis, therapy, and rehabilitation of disorders affecting any part of the nervous system. The devices which are used to perform neurosurgeries are neurosurgical devices. Which are used to perform the surgeries like oncological neurosurgery, endovascular neurosurgery, and stereotactic neurosurgery. These surgeries are performed to treat neurological disorders like tumours, trauma, and brain injuries

RelatedSocieties:

Track 14: Neuropharmacology

Neuropharmacology is the branch that deals with the study how the drugs affect the cell function in the central nervous system, and the neural mechanisms by which they influence behavioural changes. Two main branches of neuropharmacology which includes 1) behavioural neuropharmacology and 2) molecular neuropharmacology. 1) Behavioural neuropharmacology mainly deals with how drug dependence and addiction affect the human brain. 2) Molecular neuropharmacology is the study about the neurons and their neurochemical interactions. Both of these fields are closely connected, since both are concerned with the interactions. By these interactions, researchers are developing drugs to treat different neurological disorders, such as pain, neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease, psychological disorders, like addiction, and many others.

Related Societies:

Neuropathy Association & Nevus Outreach, Brain Aneurysm Foundation and Brain Injury Association of America, Brain Injury Resource Center & Brain Trauma Foundation; Brain Research Organisation; International Child Neurology Association; World Federation of Neurology; World Federation for Neuro Rehabilitation; World Federation of Neurosurgical Societies; World Psychiatric Association; Alzheimer's Disease International; Association of Parkinsonism and Related Disorders

Track 15: Neuropathology

Neuropathology is a branch which deals with the study of diseases of the nervous system, and typically that includes the laboratory analysis of tissue samples for personalized

diagnosis and forensic investigations. Neuropathologists who make these diagnoses and conduct research in this field, areas which includes are brain tumours, Alzheimer disease and neurodegenerative disorders, stroke and cerebrovascular disorders, cerebral palsy and developmental disorders of the brain.

Track 16: Neuro Therapeutics

Procedures that have been proving to be advantageous in nervous disease therapy like regenerative therapies, gene therapy, neural stem cell therapy, transracial direct current stimulation therapy etc.

Welcome to our Symposium at the Brain Injury 2018 Conference in Amsterdam

It´s a pleasure for me to introduce my colleagues to this event. I´m proud to present our group of therapists that come from different areas to Amsterdam: Neuropsychology (Adrian Gaitan), Stress Medicine (Dr. Wolfram Kersten), Occupational Therapy (Thomas Feiner). We all are united to show how we successfully integrate Neurofeedback into our daily clincial practice.

As a Co-Organizer of the international Brain Injury 2018 Conference I´m very happy to show also other professionials in the medical field how they also could help their clients to achieve better results. Brain injury has many different pictures; we show you from our perspective what is a threat for the brain, and how we can help the brain to recover from very severe conditions by making use of the knowledge which is available.

So we hope to see you there at our symposium at the Brain Injury 2018 Conference. I´m sure you will be very excited.

Thomas Feiner, BCIA BCN

Director of the Institute for EEG-Neurofeedback

Germany

On behalf of Conference organizing Committee we would like to officially invite you for 7^th International Conference on Brain Injury and Neurological Disorders held during April 10-12, 2018 in Amsterdam, Netherlands

Theme: Explore the Latest Innovative Treatment and Prevention of Brain Injury

Brain Injury 2018 Conference will give a perfect platform to discuss and sharing the knowledge and ideas on brain injury. These meetings provide an ideal combination of excellent science, an open atmosphere and allowing attendees and speakers to easily focus on academic exchange of ideas.

The main aim of the 7^th International Conference on Brain Injury and Neurological Disorders is to provide an opportunity for establishing collegial relationships with the international professionals focused on the science of brain injury research.

Planning a Trip to Amsterdam!! Attending Meeting!!!

Issue with VISA!!

Brain Injury 2018 Committee will be happy to help you in all regards to plan your trip to Amsterdam Netherlands, Avail the official invitation letter from us to attend this event and ahead with a closer step for approval of your VISA

Mail to: braininjury@neuroconferences.com

eurobraininjury@neuroconferences.com

Best Tourist Destination: Amsterdam, Netherlands:

Delft city hall
Amsterdam West church
Garden of Europe
Efteling Theme Park
Canals of Amsterdam
Rijks Museum
Amsterdam port
Amsterdam Royal Palace
Van Gogh Museum
Science Center NEMO
Rembrandt House Museum
Oude Kerk and many more……

A Neurological disorder has become a growing threat, because of the demographic change and the resulting increase in the elderly populations in Europe. Worldwide there is an over 46 million Alzheimer’s patients and in India over 4 million people are suffering with some type of dementia and the number is estimated to rise to about 131.5 million by 2050.Mental health and research on neuropsychiatric diseases were priorities, with more than EUR 280 million invested since 2007. Brain diseases account for 35% of the overall disease burden and the cost European society almost euro 400 billion per year. Neurological and psychiatric disorders affect a growing number of individuals, nearly, one in five Americans in a year and about two billion people globally.

Each year 600,000 people are newly diagnosed with the neurological condition. 19% of hospital admissions are for the treatment of neurological problem from a neurologist or neurosurgeon mostly for stroke, epilepsy, dementia, and head injury.

The European pharmaceutical industry spent an approximately of €3.3 billion for the brain research per year, corresponding to that 79% of the total funding for brain research in Europe. Research on neuropsychiatric diseases such as depression or schizophrenia has been supported with EUR 283 million. In Europe overall, the neurological damage accounts for the 40% of people who are severely disabled and who are need in daily help. The global neuroscience market size will be reach up to the $30.80 billion by 2020 from $24.09 Billion in 2013, growing at CAGR of 2.9%. The Asia Pacific industry for neuroscience is estimated to grow at a Compound Annual Growth Rate of nearly 3.0% over the forecast period to reach a revenue over USD 8.00 billion by 2020. The global market for the Neuromarketing technology is expected to reach about $22.0 million by 2021, increasing at a compound annual growth rate of 18.0% from 2016 to 2021.

Geographically, neurological disorder drugs market has been segmented into the 10 major regions: Germany, Switzerland, , Italy, Russia,Spain,U.K., Switzerland, Netherlands, France ,Poland and Rest of the Europe. The market for the neurological disorder drugs has been extensively analyzed which is based on their usefulness, effectiveness, sales revenue and also geographic presence. The market size and the forecast in terms of US$ Mn for each disorder, and drug class, distribution channel as well as the geographic regions has been provided for the period of 2016 to 2024. Report on this neurological disorder drugs market also provides the compound annual growth rate (CAGR %) for the each market segment for the forecast period from 2016 to 2024, considering the 2015 as the base year.

Important and scope:

Neurological disorders Is a unique forum to bring worldwide distinguished academics in the field of neuroscience and neurology, Brain researchers, public health professionals, scientists, academic scientists, industry researchers, scholars to exchange about state of the art research and technologies.

The main aim of this conference is to stimulate the new ideas for the treatment that will be beneficial across the spectrum of Neuroscience.

Neurological disorders: This public health challenges describes and discusses about the increasing global public health importance of the common neurological disorders like dementia, epilepsy, headache, multiple sclerosis, and neuroinfections, neurological disorders which are associated with malnutrition, pain associated with the neurological disorders, Parkinson ’s disease, stroke, traumatic brain injuries.

Why Amsterdam, Netherlands:

Amsterdam is the Netherlands’ capital it has a population of about 851,373 within the city proper, and 1,351,587 in the urban area and 2,410,960 in the Amsterdam metropolitan area.

As per the period of 2010–2012, annually 34,681 patients visited the ED due to the TBI, comprising about 4% of the total injury-related ED visits per year in Netherlands. The overall incidence rate of ED visits due to TBI was 213.6 per 100,000 person years, 241.9 for males, 175.3 for females. Incidence rates were highest in children 268.2, young adults 271.6 and older patients 75–84 years 307.6 or 85 and older 578.2. The estimated total costs of TBI in Netherlands was about €314.6 million per year.

Who to attend:

Neurophysiologists, Neurologists, Paediatric Neurologists, Neurosurgeons, physiatrists, Research scientists, Neurology Organizations, and Epileptologists Pharmaceutical companies, Neuro and CNS drug Industries, Neuroscience associations, Neuroscience foundations, neuroradiologists, Professors, Students from Academia in the study of Neurology and Neurophysiology and researchers who utilize neurophysiological techniques and also knowledge in diagnosing and in treating nervous system disorders, social workers.

Conference Highlights:

Brain Disorder

Development Disorders

Dementia

Neurodegenerative disorders

Peripheral Neuropathy

Central Nervous system Disorders

Brain Stroke

Spinal cord disorders

Psychiatric Disorders

Neuro Imaging and Radiology

Brain Mapping

Neurosurgery

Neuropharmacology

Neuropathology

Neuroinformatics

Neurotechnology

Neurogenetics

Target Audience:

Academia 60%

Industry 30%

Others 10%

Scope of the Neurological Disorder Drugs Industry on the basis of region:

North America

Europe

China

Japan

Southeast Asia

India

Following are the key players covered in this Neurological Disorder Drugs Market research report:

Novartis AG

GlaxoSmithKline plc

Merck & Co.

Bayer AG

AstraZeneca

Boehringer Ingelheim GmbH

F. Hoffmann-La Roche Ltd.

List of Assciation/ Societies around the world:

American Board of Psychiatry and Neurology (ABPN)

American Academy of Neurology (AAN)

American Society of Neuroimaging

American Spinal Injury Association

American Epilepsy Society

American Association of Neurological Surgeons

Child Neurology Society

European Federation of Neurological Societies

National Institute of Neurological Disorders and Stroke

The American Clinical Neurophysiology Society

Indian Academy of Neurology

Neurological Society of India

Alzheimer Europe

American Academy of Neurology

American Academy of Sleep Medicine

The American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM)

American Association of Neurological Surgeons

American Autonomic Society

American Epilepsy Society

American Headache Society

American Neurological Association

American Society of Electroneurodiagnostic Technologists

American Society of Neuroimaging

American Synesthesia Association

Associated Professional Sleep Societies

Australasian Stroke Trials Network

Austrian Neurological Association

Belgian Neurological Society

Belgian Society of Pediatric Neurology

Brain Trauma Foundation

British Columbia Society of Electroneurophysiology Technologists

British Paediatric Neurology Association

Cervical Spine Research Society

Cervical Spine Research Society - European Section

Child Neurology Society

Czech Neurological Society

Czech Neuropsychopharmacological Society

Danish Neurological Society

Dutch Society of Neurology

Dystonia Medical Research Foundation

Egyptian Society of Neurology, Psychiatry and Neurosurgery

Euro-Ataxia:

European Charcot Foundation

Neuroscience Research Centers:

Allen Institute

Blanchette Rockefeller Neurosciences Institute

Bernstein Focus: Neurotechnology

CIMIT Neurotechnology Program

Gladstone Institute of Neurological Disease

The Ontario Brain Institute (OBI)

The Van der Veer Institute for Parkinson's and Brain Research

Top Companies:

ACADIA Pharmaceuticals

Accera

Acorda Therapeutics

Agenebio

Alcobra Pharmaceuticals

Anthrotronix

Aptuit

Biogen Idec

Cerecor

ElMindA

Embera NeuroTherapeutics

Forum Pharmaceuticals

Medivation

Microtransponder

Neurocrine Biosciences

Neuronix Medical

NeuroElectrics

NeuroPace

nLife Therapeutics

Photopharmics

Posit Science

Hospitals:

Norfolk and Norwich Hospital

Ipswich Hospital

Lincoln County Hospital

Leicester General Hospital

St Mary's Hospital

Guy's Hospital

St Thomas' Hospital

The Hammersmith Hospital

Sunderland Royal Hospital

Royal Manchester Children's Hospital

Macclesfield District General Hospital

The Great Western Hospital

Poole General Hospital

Musgrove Park Hospital

Royal Devon and Exeter Hospital

Royal Cornwall Hospital

Neurological disorder Market Statistics:

The global market for the neurological disease treatment and medication was worth of $12.6 billion in the year 2006 and it will reach up to the $14 billion by 2007. At a compound annual growth rate 11.6%, the global market will be the worth of almost $24.3 billion by the year 2012.

Drugs for the multiple sclerosis, Alzheimer's disease, and the Parkinson's disease control approximately the 99% of the total market share.

Medications for the multiple sclerosis are just over the 35% greater than market share of medication for the Alzheimer's disease, despite the fact that there are fewer patients with MS. As AD drugs become the more prevalent, the shares of the market could change dramatically.

An estimated of 6.8 million people die every year as a result of neurological disorders. In Europe, the economic cost of the neurological diseases was estimated about the 139 billion euros in the year 2004. Access to appropriate care is difficult for the many people with the neurological disorders, their families and the caregivers. WHO advocates for the integration of neurological care into primary health care. For many people, the primary health care is the only access to the medical care they have. In these settings, the doctors can use low-technology interventions. Community-based rehabilitation is also one of the options.

Past Conference Report

Firstly we would like to thank all of our wonderful speakers, conference attendees, students, associations and guests for making Euro Brain Injury-2017 a wonderful event!

3^rd International Conference on Neurological Disorders and Brain Injury was organized during April 18-19, 2017 at London, UK. With the support and contribution of the Organizing Committee Members, we successfully hosted the event at the conference venue.

Firstly we must thank you for trusting us and participating at Brain injury 2017, a global platform to discuss various important aspects in the field of Brain Injury.

The conference was organized around the theme “Scientific Assessment of Neurological Disorders and Brain Injury”. We invited Neurophysiologists, Neurologists, Paediatric Neurologists, Neurosurgeons, physiatrists, Research scientists, Neurology Organizations, and Epileptologists Pharmaceutical companies, Neuro and CNS drug Industries, Neuroscience associations, Neuroscience foundations, neuroradiologists, Professors, Students from Academia in the study of Neurology and Neurophysiology and researchers who utilize neurophysiological techniques and also knowledge in diagnosing and in treating nervous system disorders, social workers.

Conference highlights includes: Neurology of Brain, Neurodegenerative diseases, Cerebro Spinal Complications, Brain Disorder: Pathophysiology, Brain Disorders, Brain Stem Stroke, Brain Surgery, Clinical Management of Brain Injury, Diagnosis/Assessment of Brain Injury, Brain Injury Biomarkers, Brain Therapeutics, Animal models in Brain Research, Case Reports and Case Management of Brain Injuries, Neurological Disorders, Brain Injury Medicine, Brain Injury Mental Retardation, Brain Injury Treatment, Fatal & Neonatal Brain Injury, Neurobehavioral Disorders, Neurosurgery, Pediatric Brain Injury, Traumatic Brain Injury

The conference proceedings were carried out through various Scientific-sessions and plenary lectures, of which the following Speakers were highlighted as Keynote speakers: Suresh Kumar- Headaches, TBI and Memory Research Institute, USA; Fontaine H Guy-Pitié-Salpêtrière Hospital, France; Aguinaldo Pereira Catanoce- Pontifi cia Catholica University of Campinas, Brazil; Esther M Remeta- Chiropractic Research Institute, USA; Chair: Esther M Remeta- Chiropractic Research Institute, USA; Fagogenis Gerasimos- Athens University School of Medicine Postgraduate, Greece;

We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank the Organizing Committee Members

· Suresh Kumar (Director, TBI & Memory Research Institute & Regain Memory Center,USA

· Susanna Rosi (Director, of Neurocognitive Research, Brain and Spinal Injury Center, University of California, San Francisco, USA)

· Alexandre Amaral (Director & Professor, Hospital Federal dos Servidores do Estado, Brazil)

· Harish C Pant (Senior Investigator, NINDS, USA)

· Aguinaldo Pereira Catanoce (Director, University Hospital Technical Puc Campinas., Brazil)

· Wai Kwong Tang (Professor, Chinese University of Hong Kong, China)

· Bibiana Bielekova (Professor, National Institutes of Health, USA)

· Rong Fu Wang (Director & Professor, Center & Peking University First Hospita, China)

· Ivan G. Milanov (President, BULGARIAN SOCIETY OF NEUROLOGY, Bulgaria)

With the grand success of Euro Brain Injury -2017, Conference series llc LTD is feeling proud to announce the upcoming “7^th International Conference on Brain Injury and Neurological Disorders " to be held during April 10-12, 2018 at Amsterdam, Netherlands

Mark your calendars for the upcoming meeting; we are hoping to see you soon!

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	April 10-12, 2018
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1	Day 2	Day 3
Poster Opportunity Closed	Click Here to View

7^{^th} International Conference on Brain Injury and Neurological Disorders April 10-12, 2018 Amsterdam, Netherlands

Recommended Global Neuroscience Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

Renowned Speakers

Brain Injury 2018

Past Conference Report

Conference Highlights

To Collaborate Scientific Professionals around the World

Useful Links

Special Issues